Rationale and Design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes) 3-4 Study (Q83442994)

From Wikidata

Jump to navigation Jump to search

scientific article published on February 17, 2011

Language	Label	Description	Also known as
English	Rationale and Design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes) 3-4 Study	scientific article published on February 17, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21333426%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21333426%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Rationale and Design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes) 3-4 Study (English)

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

autosomal dominant polycystic kidney disease

1 reference

based on heuristic

inferred from title

autosomal dominant polycystic kidney

1 reference

based on heuristic

inferred from title

antidiuretic hormone receptor antagonists

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21333426

24 November 2024

Vicente E Torres

1

object named as

Vicente E. Torres

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21333426

24 November 2024

Olivier Devuyst

5

object named as

Olivier Devuyst

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21333426

24 November 2024

author name string

Esther Meijer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21333426%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Eiji Higashihara

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21333426%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Kyongtae T. Bae

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21333426

24 November 2024

Arlene B. Chapman

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21333426

24 November 2024

Ron T. Gansevoort

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21333426

24 November 2024

Jared J. Grantham

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21333426

24 November 2024

Ronald D. Perrone

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21333426

24 November 2024

Holly B. Krasa

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21333426

24 November 2024

John J. Ouyang

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21333426

24 November 2024

Frank S. Czerwiec

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21333426

24 November 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21333426

24 November 2024

publication date

17 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21333426%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

full work available at URL

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21333426/?tool=EBI

online access status

content deliverer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21333426

24 November 2024

https://api.elsevier.com/content/article/PII:S0272638610017841?httpAccept=text/xml

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

https://api.elsevier.com/content/article/PII:S0272638610017841?httpAccept=text/plain

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

American Journal of Kidney Diseases

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21333426%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

57

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21333426%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21333426%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

692-699

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21333426%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Polycystic kidney disease: The complete structure of the PKD1 gene and its protein

1

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease

2

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Autosomal dominant polycystic kidney disease

3

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes

4

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Volume progression in polycystic kidney disease

5

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Autosomal dominant polycystic kidney disease: time for a change?

6

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Lillian Jean Kaplan International Prize for advancement in the understanding of polycystic kidney disease. Understanding polycystic kidney disease: a systems biology approach

7

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys

8

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Vasopressin V2 receptor expression along rat, mouse, and human renal epithelia with focus on TAL

9

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Vasopressin antagonists in polycystic kidney disease

10

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist

11

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease

12

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Expansion of extracellular volume in early polycystic kidney disease

13

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat.

15

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Vasopressin directly regulates cyst growth in polycystic kidney disease

16

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia

17

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial

18

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial

19

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1.

23

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Prediction of creatinine clearance from serum creatinine

24

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

The power to detect differences in average rates of change in longitudinal studies

25

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Volumetric measurement of renal cysts and parenchyma using MRI: phantoms and patients with polycystic kidney disease

28

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort

29

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months

30

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Everolimus in patients with autosomal dominant polycystic kidney disease.

31

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Sirolimus and kidney growth in autosomal dominant polycystic kidney disease

32

1 reference

10.1053/J.AJKD.2010.11.029

https://api.crossref.org/works/10.1053/J.AJKD.2010.11.029

24 November 2024

Identifiers

10.1053/J.AJKD.2010.11.029

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21333426%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21333426%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83442994&oldid=2279291701"